Phase 3 trial of Biogen and UCB's dapirolizumab pegol shows significant improvement in lupus disease activity. Read more here ...

After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...

A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active ...

The Bangladesh Securities and Exchange Commission (BSEC) yesterday approved the issuance of subordinated bonds totalling Tk2,000 crore by five banks to strengthen their Tier-2 capital base. All the ...

Bitcoin has kept refreshing all-time highs over the past few days, leading to increased investors’ interests but also ...

When equity investors are struggling amid the inflationary cycle, smart investors continue to rush into fixed income for the third consecutive year. Bangladesh's equity-focused mutual fund industry ...

Biogen and UCB on Tuesday shared an expanded dataset for their Phase 3 lupus program, which they said two months ago ...

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

European markets are expected to open on Tuesday on a positive note even as markets focus on the health of the corporate sector and ...

CareMessage, the largest patient activation platform in the United States for underserved populations, today announced the launch of their AI Assistant, adding ethical AI tools to their market-leading ...